09 December 2015: Clinical Research
Elevated Whole-Blood Viscosity is Associated with Gallstones
Ji-bin Yin BCEF , Ying Li BCDF , Tiemin Liu AF , Rui-tao Wang ABCDEF
DOI: 10.12659/MSM.895373
Med Sci Monit 2015; 21:3847-3852
Abstract
BACKGROUND: Gallstones are associated with dyslipidemia, metabolic syndrome, hyperinsulinemia, and carotid intima-media thickness, which all are related to hyperviscosity. Therefore, this study aimed to examine the associations between blood viscosity and gallstones.
MATERIAL AND METHODS: We investigated the associations between blood viscosity and gallstones in a study conducted in middle-aged subjects.
RESULTS: Among 849 enrolled patients, 421 (49.6%) had gallstone disease. Compared with control subjects, whole-blood viscosity (WBV) levels were increased in patients with gallstones. The prevalence of gallstones increased as WBV (3 s–1) quartiles increased. Furthermore, logistic regression analysis showed that WBV (3 s–1) was associated with gallstone disease.
CONCLUSIONS: We found that whole-blood viscosity at low shear rate was independently associated with gallstones. Whether control of hyperviscosity would reduce the risk of developing gallstones deserves further investigation.
Keywords: Blood Viscosity, Gallstones, Risk Factors
Background
Gallstone disease is one of the most common gastroenterological disorders in Western counties. Gallstones are associated with the potential risks of the development of cholecystitis, pancreatitis, biliary tract obstruction, and gall bladder cancer [1]. Recent studies documented that dyslipidemia, metabolic syndrome, hyperinsulinemia, and carotid intima-media thickness are related to the development of gallstones [2–6].
Altered hemorheological parameters play an important role in atherogenesis. Elevated viscosity is associated with aging, obesity, metabolic syndrome, insulin resistance, carotid intima-media thickness, and diabetes mellitus [7–11]. A report found that whole-blood viscosity (WBV) is an independent predictor of cardiovascular diseases [12].
However, the association between blood viscosity and gallstones is uncertain. Therefore, the aim of this study was to test the hypothesis that WBV is associated with gallstone disease.
Material and Methods
STUDY POPULATION:
Our study included 1774 participants who attended International Physical Examination and Healthy Center in Harbin between January 2013 and December 2013. Control subjects were matched for age, sex, smoking, and drinking. In China, the Health Law requires that employees participate in annual health examination. We excluded 382 subjects with anaemia, chronic hepatic or renal disease, cancer, cystic fibrosis, Crohn’s disease, gastrectomy, prophylactic cholecystectomy, medical treatment with hormone replacement therapy and lipid-lowering agents. We also ruled out hypertension, diabetes, and cardiovascular diseases (n=426). We excluded 117 participants with missing data were excluded, leaving 849 subjects in the final analysis. Study participants gave written informed consent and ethics approval was obtained from the Ethics Committee of the Second Hospital of Harbin Medical University.
CLINICAL EXAMINATION:
All participants underwent a thorough examination, including comprehensive medical history, lifestyle behaviors, physical examination, medication use, and fasting blood samples. Participants were asked about lifestyle behaviors, including cigarette smoking, alcohol consumption, and physical activity. Arterial blood pressure was measured by a mercury sphygmomanometer in a sitting position after the patient had been resting for 15 minutes. Two blood pressure determinations were made and the average was used for analyses. Height and weight were measured, and body mass index (kg/m2) was calculated.
BIOCHEMICAL ANALYSES:
Blood samples were drawn after the participants had fasted overnight. Total cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), triglyceride (TG), and fasting plasma glucose (FPG) were determined by standard automated bioassays (Modular Analytics, Roche, Mannheim, Germany). Whole-blood viscosity was assayed at shear rates between 3 s−1 and 200 s−1 corrected hematocrit of 45% at 37°C using a Cone/Plate viscometer (Succeeder SA-9000, Beijing, China). Blood viscosity was corrected to a standard hematocrit of 45% by a regression equation [13]. The resistance to rotation caused by the fluid produces a value that is proportional to the viscosity of the sample. For high shear rate, the intra- and inter-assay coefficient variations were 2.7 and 5.6%, respectively. For low shear rate, the intra- and inter-assay coefficient variations were 4.6 and 9.8%, respectively. Plasma viscosity was evaluated by Harkness method. Hematocrit was determined by microcentrifugation and hemoglobin was measured with an autoanalyzer (Sysmex XE-2100, Kobe, Japan). Plasma fibrinogen was determined using the Beckman Coulter ACL-TOP analyzer (Lexington, MA, USA). All measurements were conducted within 2 h of sampling.
DIAGNOSTIC CRITERIA:
Glomerular filtration rate (eGFR) was estimated using the Modification of Diet in Renal Disease (MDRD) equation. MDRD equation was:
The abdominal ultrasonography was performed by an experienced ultrasonographer using a sonography machine (Voluson E8, GE, America) with a 3.5-MHz probe. The ultrasonographer was unaware of the objectives of the study and blinded to laboratory values. Gallstones were defined by the presence of strong intraluminal echoes that were gravity-dependent or that attenuated ultrasound transmission (acoustic shadow).
STATISTICAL ANALYSIS:
Data were expressed as median/inter-quartile range (IQR), mean (SD), and percentages. Normally distributed continuous variables were compared with the
Results
The characteristics stratified by gallstones are shown in Table 1. Patients with gallstones were less active, and had higher BMI, TG, WBV (3 s−1), WBV (200 s−1) and lower HDL compared with control subjects. However, no significant differences were observed for age, sex, drinking, smoking, SBP, DBP, LDL, TC, FPG, GGT, fibrinogen, plasma viscosity, hemoglobin, hematocrit, or eGFR between the 2 groups.
Table 2 shows the characteristics of the participants according to WBV (3 s−1) quartiles. Mean BMI, SBP, DBP, hematocrit, fibrinogen, plasma viscosity, WBV (200 s−1), and the percentage of male and smoker elevated gradually as WBV (3 s−1) increased. However, HDL was decreased as WBV (3 s−1) quartiles increased. Age, FPG, TC, TG, LDL, GGT, eGFR, hemoglobin, the percentage of drinking, and physical activity did not change as WBV (3 s−1) quartiles increased.
The incidence of gallstones was calculated by the quartiles of WBV (3 s−1) levels. The WBV (3 s−1) quartiles were quartile 1 (Q1) (≤7.56 mPa.s), quartile 2 (Q2) (7.57–8.35 mPa.s), quartile 3 (Q3) (8.36–9.13 mPa.s), and quartile 4 (Q4) (≥9.14 mPa.s). The incidence rates of gallstones in Q1, Q2, Q3, and Q4 were 12.68% (27/213), 41.31% (88/213), 63.85% (136/213), and 80.95% (170/210), respectively. The incidence rate in different quartiles showed a significant difference (
Risk factors for gallstones were evaluated using logistic regression analysis in Table 3. For multiple regression, factors showing a value P<0.20 in Table 1 were selected to enter into the original model. BMI, physical activity, HDL, TG, WBV (3 s−1), and WBV (200 s−1) were significantly associated with gallstones in the model. Notably, WBV (3 s−1) was found to be a “newly observed” independent risk factor for gallstone disease (OR: 2.552, 95% CI: 2.144–3.037;
Discussion
In this study, we found that WBV levels elevated in patients with gallstones compared with control subjects. The prevalence of gallstones increased as WBV (3 s−1) quartiles increased.
The mechanisms underlying the association between WBV and gallstones remain unclear. Some reports documented that elevated viscosity is associated with obesity, metabolic syndrome, insulin resistance, and diabetes mellitus [7–11]. Blood viscosity is inversely related to flow and contributes to flow-related insulin resistance [14]. Recent studies confirmed the link between increased blood viscosity and insulin resistance [15–17]. Insulin resistance plays key roles both in the pathogenesis of type 2 diabetes and in the development of cholelithiasis [18]. Moreover, hyperinsulinemia increases gallstone formation by increasing the activity of hydroxyl-3-methylglutaryl-coenzyme and directly stimulating the bile acid-independent flow of bile into the perfused liver [19,20]. A recent study confirmed that hepatic insulin resistance directly promotes formation of cholesterol gallstones [21]. In addition, the size of stones inversely correlated with the severity of inflammation [22]. Obesity, dyslipidemia, insulin resistance, and metabolic syndrome all frequently co-occur in gallstone disease and have contributed to the development of gallstones [23,24]. Further studies are needed to investigate the relationship among hyperviscosity syndrome, insulin resistance, and gallstones.
Our study has important clinical implications. We showed that increased blood viscosity is associated with gallstone disease. The implication is that a much broader approach needs to be taken for the prevention of gallstones. Reasonable control of hyperviscosity may be necessary for patients with gallstones.
There are some limitations in the study. First, based on the cross-sectional analysis, the present findings cannot be used to indicate whether WBV is the cause or consequence of gallstones. Second, this study comprised a selected group of Chinese subjects, so the results cannot be generalized directly to other ethnic groups.
Conclusions
We found that whole-blood viscosity at low shear rate was independently associated with gallstones. Whether control of hyperviscosity would reduce the risk of developing gallstones deserves further investigation.
References
1. Liu CM, Tung TH, Chou P, Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital: World J Gastroenterol, 2006; 12(8); 1281-86, pmid: 16534886
2. Grundy SM, Cholesterol gallstones: a fellow traveler with metabolic syndrome: Am J Clin Nutr, 2004; 80(1); 1-2, pmid: 15213019
3. Nervi F, Miquel JF, Alvarez M, Gallbladder disease is associated with insulin resistance in a high risk Hispanic population: J Hepatol, 2006; 45(2); 299-305, pmid: 16516330
4. Kim JH, Ryoo JG, Lee JW, Kim JH, Gallstones are associated with intima-media thickness of common carotid arteries in men: Korean J Fam Med, 2014; 35(3); 136-42, pmid: 24921032
5. Mendez-Sanchez N, Bahena-Aponte J, Chavez-Tapia NC, Strong association between gallstones and cardiovascular disease: Am J Gastroenterol, 2005; 100(4); 827-30, pmid: 15784027
6. Weikert C, Weikert S, Schulze MB, Presence of gallstones or kidney stones and risk of type 2 diabetes: Am J Epidemiol, 2010; 171(4); 447-54, pmid: 20089496
7. Carallo C, Irace C, De Franceschi MS, The effect of aging on blood and plasma viscosity. An 11.6 years follow-up study: Clin Hemorheol Microcirc, 2011; 47(1); 67-74, pmid: 21321410
8. Velcheva I, Antonova N, Titianova E, Hemorheological parameters in correlation with the risk factors for carotid atherosclerosis: Clin Hemorheol Microcirc, 2006; 35(1–2); 195-98, pmid: 16899926
9. Wiewiora M, Sosada K, Slowinska L, Sex-dependent differences in rheological properties and the relation of blood viscosity to erythrocyte aggregation indices among morbidly obese patients: Clin Hemorheol Microcirc, 2010; 44(4); 259-67, pmid: 20571240
10. Vaya A, Hernandez-Mijares A, Bonet E, Association between hemorheological alterations and metabolic syndrome: Clin Hemorheol Microcirc, 2011; 49(1–4); 493-503, pmid: 22214720
11. Tamariz LJ, Young JH, Pankow JS, Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study: Am J Epidemiol, 2008; 168(10); 1153-60, pmid: 18931370
12. Lowe GD, Lee AJ, Rumley A, Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study: Br J Haematol, 1997; 96(1); 168-73, pmid: 9012704
13. Baskurt OK, Meiselman HJ: Microcirculation, 2008; 15(7); 585-90, pmid: 18608991
14. Kesmarky G, Kenyeres P, Rabai M, Toth K, Plasma viscosity: a forgotten variable: Clin Hemorheol Microcirc, 2008; 39(1–4); 243-46, pmid: 18503132
15. Perez-Martin A, Dumortier M, Pierrisnard E, Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance: Clin Hemorheol Microcirc, 2001; 25(3–4); 91-103, pmid: 11847412
16. Hoieggen A, Fossum E, Moan A, Whole-blood viscosity and the insulin-resistance syndrome: J Hypertens, 1998; 16(2); 203-10, pmid: 9535148
17. Sola E, Vaya A, Simo M, Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance: Clin Hemorheol Microcirc, 2007; 37(4); 309-18, pmid: 17942983
18. Zanlungo S, Miquel JF, Rigotti A, Nervi F, Insulin and cholesterol gallstones: new insights for a complex pathogenic relationship: Hepatology, 2008; 48(6); 2078-80, pmid: 19026006
19. Nepokroeff CM, Lakshmanan MR, Ness GC, Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone: Arch Biochem Biophys, 1974; 160(2); 387-96, pmid: 4364764
20. Storer GB, Topping DL, Trimble RP, Direct stimulation by glucose and insulin of glycogen synthesis in perfused rat liver: FEBS Lett, 1981; 136(1); 135-37, pmid: 7032973
21. Biddinger SB, Haas JT, Yu BB, Hepatic insulin resistance directly promotes formation of cholesterol gallstones: Nat Med, 2008; 14(7); 778-82, pmid: 18587407
22. Sipos P, Krisztina H, Blazovics A, Feher J, Cholecystitis, gallstones and free radical reactions in human gallbladder: Med Sci Monit, 2001; 7(1); 84-48, pmid: 11208499
23. Stokes CS, Krawczyk M, Lammert F, Gallstones: environment, lifestyle and genes: Dig Dis, 2011; 29(2); 191-201, pmid: 21734384
24. Muszyński J, Konarska L, Wierzbicki Z, Kowalczyk A, The effect of cholecystectomy on the chemical composition of bile and on the lithogenic index of bile in patients with gallstones: Med Sci Monit, 1996; 2(2); CR187-92
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






